المؤلفون: W. Cameron Black, Abbas Abdoli, Xiuli An, Anick Auger, Patrick Beaulieu, Michel Bernatchez, Cathy Caron, Amandine Chefson, Sheldon Crane, Mohamed Diallo, Stéphane Dorich, Lee D. Fader, Gino B. Ferraro, Sara Fournier, Qi Gao, Yelena Ginzburg, Martine Hamel, Yongshuai Han, Paul Jones, Stéphanie Lanoix, Cyrus M. Lacbay, Marie-Eve Leclaire, Maayan Levy, Yael Mamane, Amina Mulani, Robert Papp, Charles Pellerin, Audrey Picard, Alexander Skeldon, Kathryn Skorey, Rino Stocco, Miguel St.-Onge, Jean-François Truchon, Vouy Linh Truong, Michal Zimmermann, Michael Zinda, Anne Roulston

مصطلحات موضوعية: Biophysics, Biochemistry, Cell Biology, Genetics, Molecular Biology, Pharmacology, Biotechnology, Immunology, Cancer, Science Policy, Virology, Computational Biology, Biological Sciences not elsewhere classified, Chemical Sciences not elsewhere classified, preclinical evaluation focused, intermittent dosing schedules, excellent adme properties, related kinase mtor, key hydrogen bond, key kinase, synthetic lethal, single agent, pharmacophore model, nct04855656 ), mitigate anemia, erythroid compartment, damage response, attractive target, allow recovery

Relation: https://figshare.com/articles/journal_contribution/Discovery_of_the_Potent_and_Selective_ATR_Inhibitor_Camonsertib_RP-3500_/25126367

الاتاحة: https://doi.org/10.1021/acs.jmedchem.3c01917.s001
https://figshare.com/articles/journal_contribution/Discovery_of_the_Potent_and_Selective_ATR_Inhibitor_Camonsertib_RP-3500_/25126367

المؤلفون: W. Cameron Black, Abbas Abdoli, Xiuli An, Anick Auger, Patrick Beaulieu, Michel Bernatchez, Cathy Caron, Amandine Chefson, Sheldon Crane, Mohamed Diallo, Stéphane Dorich, Lee D. Fader, Gino B. Ferraro, Sara Fournier, Qi Gao, Yelena Ginzburg, Martine Hamel, Yongshuai Han, Paul Jones, Stéphanie Lanoix, Cyrus M. Lacbay, Marie-Eve Leclaire, Maayan Levy, Yael Mamane, Amina Mulani, Robert Papp, Charles Pellerin, Audrey Picard, Alexander Skeldon, Kathryn Skorey, Rino Stocco, Miguel St.-Onge, Jean-François Truchon, Vouy Linh Truong, Michal Zimmermann, Michael Zinda, Anne Roulston

مصطلحات موضوعية: Biophysics, Biochemistry, Cell Biology, Genetics, Molecular Biology, Pharmacology, Biotechnology, Immunology, Cancer, Science Policy, Virology, Computational Biology, Biological Sciences not elsewhere classified, Chemical Sciences not elsewhere classified, preclinical evaluation focused, intermittent dosing schedules, excellent adme properties, related kinase mtor, key hydrogen bond, key kinase, synthetic lethal, single agent, pharmacophore model, nct04855656 ), mitigate anemia, erythroid compartment, damage response, attractive target, allow recovery

Relation: https://figshare.com/articles/journal_contribution/Discovery_of_the_Potent_and_Selective_ATR_Inhibitor_Camonsertib_RP-3500_/25126367

الاتاحة: https://doi.org/10.1021/acs.jmedchem.3c01917.s001

المؤلفون: W. Cameron Black, Abbas Abdoli, Xiuli An, Anick Auger, Patrick Beaulieu, Michel Bernatchez, Cathy Caron, Amandine Chefson, Sheldon Crane, Mohamed Diallo, Stéphane Dorich, Lee D. Fader, Gino B. Ferraro, Sara Fournier, Qi Gao, Yelena Ginzburg, Martine Hamel, Yongshuai Han, Paul Jones, Stéphanie Lanoix, Cyrus M. Lacbay, Marie-Eve Leclaire, Maayan Levy, Yael Mamane, Amina Mulani, Robert Papp, Charles Pellerin, Audrey Picard, Alexander Skeldon, Kathryn Skorey, Rino Stocco, Miguel St.-Onge, Jean-François Truchon, Vouy Linh Truong, Michal Zimmermann, Michael Zinda, Anne Roulston

مصطلحات موضوعية: Biophysics, Biochemistry, Cell Biology, Genetics, Molecular Biology, Pharmacology, Biotechnology, Immunology, Cancer, Science Policy, Virology, Computational Biology, Biological Sciences not elsewhere classified, Chemical Sciences not elsewhere classified, preclinical evaluation focused, intermittent dosing schedules, excellent adme properties, related kinase mtor, key hydrogen bond, key kinase, synthetic lethal, single agent, pharmacophore model, nct04855656 ), mitigate anemia, erythroid compartment, damage response, attractive target, allow recovery

Relation: https://figshare.com/articles/dataset/Discovery_of_the_Potent_and_Selective_ATR_Inhibitor_Camonsertib_RP-3500_/25126376

الاتاحة: https://doi.org/10.1021/acs.jmedchem.3c01917.s002
https://figshare.com/articles/dataset/Discovery_of_the_Potent_and_Selective_ATR_Inhibitor_Camonsertib_RP-3500_/25126376

المؤلفون: W. Cameron Black, Abbas Abdoli, Xiuli An, Anick Auger, Patrick Beaulieu, Michel Bernatchez, Cathy Caron, Amandine Chefson, Sheldon Crane, Mohamed Diallo, Stéphane Dorich, Lee D. Fader, Gino B. Ferraro, Sara Fournier, Qi Gao, Yelena Ginzburg, Martine Hamel, Yongshuai Han, Paul Jones, Stéphanie Lanoix, Cyrus M. Lacbay, Marie-Eve Leclaire, Maayan Levy, Yael Mamane, Amina Mulani, Robert Papp, Charles Pellerin, Audrey Picard, Alexander Skeldon, Kathryn Skorey, Rino Stocco, Miguel St.-Onge, Jean-François Truchon, Vouy Linh Truong, Michal Zimmermann, Michael Zinda, Anne Roulston

مصطلحات موضوعية: Biophysics, Biochemistry, Cell Biology, Genetics, Molecular Biology, Pharmacology, Biotechnology, Immunology, Cancer, Science Policy, Virology, Computational Biology, Biological Sciences not elsewhere classified, Chemical Sciences not elsewhere classified, preclinical evaluation focused, intermittent dosing schedules, excellent adme properties, related kinase mtor, key hydrogen bond, key kinase, synthetic lethal, single agent, pharmacophore model, nct04855656 ), mitigate anemia, erythroid compartment, damage response, attractive target, allow recovery

Relation: https://figshare.com/articles/dataset/Discovery_of_the_Potent_and_Selective_ATR_Inhibitor_Camonsertib_RP-3500_/25126376

الاتاحة: https://doi.org/10.1021/acs.jmedchem.3c01917.s002